Defeat Duchenne Canada launches 2023 Research Grant Program

Defeat Duchenne Canada (DDC) is the country’s largest charitable source of investment in cutting-edge Duchenne muscular dystrophy research. DDC have funded $16 million into the most promising international research focussed on improving outcomes for all individuals with this progressive disease.

DDC invites all investigators working on translational or clinical Duchenne research to apply to their 2023 Research Grant Program!

Defeat Duchenne Canada research grant cycle process 2023

Funding Criteria

Read the full funding criteria to learn more about the grant program.

 

Upcoming Deadlines

The deadline to submit a letter of intent is April 21st, 2023.

Submit a letter of intent through the DDC web portal.

Defeat Duchenne Canada logo.

Read next...

NEWS_Scheduled Website Maintenance

Scheduled Maintenance

Please note that this website, imPORTND, and the NNLS training platform will undergo maintenance from July 23 until July 27, 2026.

NMD4C Talent Pool

Discover Neuromuscular Talent Across Canada

The NMD4C Neuromuscular Talent Pool is now live with new trainees! We invite supervisors and research groups to explore the Talent Pool to identify candidates whose skills, experience, and interests align with your work and upcoming positions. Trainees interested in being included in the Neuromuscular Talent Pool can register by completing the short form, uploading a CV and brief personal statement outlining their experience, interests, and career goals. For more information and to access the Talent Pool, please visit our website.

2026 NMD4C Annual Meeting Registration is Open

Join Us at the 2026 NMD4C Annual Meeting on 25 September

The 2026 NMD4C Annual Meeting will take place in Calgary on Friday, September 25, 2026. The agenda will feature a brief network update, trainee and early-career recognitions, flash talks, a health economics research showcase, and a series of cross‑disciplinary and parallel clinical/pre‑clinical discussion sessions to explore key topics, including advocacy and therapy access, strategies to sustain and strengthen pre-clinical programs, and network sustainability and strategic planning.